This section features interviews with influencers in healthcare 3D printing field, including our speakers.
3D printing is certainly a powerful tool that can greatly impact healthcare. To get the most out of it, take a holistic approach to the technology. Analyze and understand how you can leverage the technology for your specific needs. Go for adoption after having a thorough understanding of the technology.
3DHEALS Influencer Interview: Dr. Chaw Sing Ho, Co-Founding Managing Director of NAMIC (National Additive Manufacturing Innovation Cluster)
Chaw Sing is the co-founding Managing Director of NAMIC (National Additive Manufacturing Innovation Cluster), a Singapore government initiative to catalyse innovation and scale industrial adoption of additive manufacturing technologies. By focusing on industrial...
Biggest obstacle – industry players interested in maintaining the status quo. Nothing can be harder than showing a new/different approach to professionals who believe that they are already doing the best job possible and that their personal way of doing things is the only right one. We never say we know better or that we can do better – we merely say there is another way – the digital way. But conveying the message the right way is a problem. The best way around is to educate. To educate about the benefits, the differences, and the challenges.
3DHEALS Influencer Interview: Mr. Erik Birkeneder, Intellectual Property Attorney and a Partner at Nixon Peabody
In 2012, when I first read “Makers, the New Industrial Revolution” by Chris Anderson I realized how transformation this technology would be and how it would impact intellectual property. I read as much as I could after that and began to seek out work in this field. After that, when I met Jenny some years ago, I was excited to walk with her on this journey of making 3D printing more accessible in health care. That motivated me to learn as much as I could about the industry, and study the IP and patent implications very carefully.
3DHEALS Influencer Interview: Dr. Pedro Martinez Seijas, Oral and Maxillofacial Surgeon at Donostia University Hospital
Pedro Martinez Seijas MD. PhD. MSc. MSc. Oral and Maxillofacial Surgeon at Donostia University Hospital (San Sebastian. Spain). HM Hospital Vigo (Spain). He is a visiting Professor in Biomedical Engineering at Mondragon University (Spain) and European Fellow Oral and...
Influencer Interview: Dr. Sanjay Prabhu, Pediatric Neuroradiologist at Boston Children’s Hospital and Assistant Professor of Radiology at the Harvard Medical School
Sanjay Prabhu is a Staff Pediatric Neuroradiologist at Boston Children's Hospital and Assistant Professor of Radiology at the Harvard Medical School. He is the founding Director of the Advanced Image Analysis Lab at Boston Children’s Hospital and Clinical Director of...
We face many technical and bureaucratic challenges in the work we do. But, more often than not, our challenges come from a shortage of funds. Nia Technologies Inc. is a non-profit organization. We are supported by CBM Canada (a disability charity), along with other foundations and donors. We are currently speaking with equity investors and exploring the idea of a Nia for-profit spin-off to support our non-profit eff
3DHEALS Influencer Interview: Dr. Sang Joon Park, CEO of MEDICALIP, Seoul National University Hospital
Sang Joon Park is Founder and CEO of MEDICALIP and Professor of the Department of Radiology at the Seoul National University Hospital in South Korea. Dr. Park graduated in computer science at the school of the engineering college. He then went to the college of...
3D Bioprinting needs to overcome the valley of death of innovation. Scalability to mass produce tissues needs to be demonstrated soon to capitalize on the excitement that we currently experience. We need better equipment, better and more controlled raw materials, and better process control. In addition, academics, industry, and government regulators need to start a conversation about the regulatory path for engineered tissues and organs soon, so that a regulatory framework exists when the first products are ready for in the human application.
3DHEALS Influencer Interview: Dr. Jeffrey Miner, Founder and Chief Scientific Officer for Viscient Biosciences
I saw a presentation by a scientist at Organovo. They had what looked like a model for normal liver function from transporters to metabolic enzymes, together with cellular context. This immediately said to me – Disease models could be transformative here.